Eris Lifesciences Limited appoints Mr. Rajeev Dalal as an Additional Independent Director Posted On: 2020-12-20 05:32:12 (Time Zone: Arizona, USA) Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of Eris Lifesciences Limited have passed a circular resolution on December 19, 2020, approving appointment of Mr. Rajeev Dalal (DIN : 00222650) as an "Additional Director (Non‐Executive Independent Director)" on the Board of Directors of the Company with effect from December 19, 2020 for a term of 5 (five) years upto December 18, 2025, subject to approval of the Shareholders of the Company. Profile Summary of Mr. Rajeev Dalal: Mr. Rajeev Dalal is a Member of the Institute of Company Secretaries of India. Further he also holds degree of Bachelor of Law and Bachelor of Commerce. He has also been a member of the Committee appointed by the Securities Exchange Board of India (SEBI) for improving disclosure standards in public documents of Corporates for Capital issues. He has over 35 years of Corporate Finance experience covering 100+ M&A (domestic and cross border) transactions and Private Equity deals in sectors such as Pharma, Chemicals, FMCG, Metals & Mining, Industrials and Financial Services. He was associated with Ernst & Young LLP as transactions partner in 2002, prior to that he was associated with Ind Global Finance Trust (a category 1 investment bank), HSBC and JM Financial in their investment banking divisions.